Radiology, Vol 205, 49-53, Copyright © 1997 by Radiological Society of North America

ARTICLES

Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT

JF Platt, IR Francis, JH Ellis and KA Reige
Department of Radiology, University of Michigan Hospital, Ann Arbor 48109-0030, USA.

PURPOSE: To assess whether contrast material enhancement findings on computed tomographic (CT) scans are useful in determination of the risk for development of hepatic metastases. MATERIALS AND METHODS: Dual- phase helical CT scans were obtained in 80 patients with nonhepatic cancer and no hepatic metastases visible at CT. Attenuation was measured on scans obtained at 25 and 40 seconds. Peak liver attenuation was determined in all cases. Unenhanced scans were obtained in 35 patients. The ratio of liver attenuation at 25 and 40 seconds to peak liver attenuation, liver enhancement values at 25 and 40 seconds, and ratio of liver enhancement at 25 and 40 seconds to peak liver enhancement were determined. RESULTS: Liver metastases developed during 18-month follow-up in 22 patients. The 25- and 40-second liver enhancement values and the liver enhancement and attenuation ratios were higher in these patients than in those who did not develop metastases (P < .01). Enhancement values and ratios were more accurate than densitometric measurements for predicting development of metastases. Use of an optimal threshold (0.40 or greater) for the 40- second enhancement ratio resulted in a sensitivity of 75%, specificity of 96%, and overall accuracy of 89%. CONCLUSION: CT measurements may help in the prediction of risk for subsequent development of hepatic metastases.

This article has been cited by other articles:

				T. S. Koh, C. H. Thng, P. S. Lee, S. Hartono, H. Rumpel, B. C. Goh, and S. Bisdas Hepatic Metastases: In Vivo Assessment of Perfusion Parameters at Dynamic Contrast-enhanced MR Imaging with Dual-Input Two-Compartment Tracer Kinetics Model Radiology, October 1, 2008; 249(1): 307 - 320. [Abstract] [Full Text] [PDF]

				J. B. Kruskal Can Optical Imaging Assist in Characterization of the Onset of Angiogenesis in Developing Hepatic Metastases in Mice Livers? Radiology, May 1, 2007; 243(2): 307 - 308. [Full Text] [PDF]

				Z. Kan, S. Kobayashi, S. Phongkitkarun, and C. Charnsangavej Functional CT Quantification of Tumor Perfusion after Transhepatic Arterial Embolization in a Rat Model Radiology, October 1, 2005; 237(1): 144 - 150. [Abstract] [Full Text] [PDF]

				Z. Kan, S. Phongkitkarun, S. Kobayashi, Y. Tang, L. M. Ellis, T. Y. Lee, and C. Charnsangavej Functional CT for Quantifying Tumor Perfusion in Antiangiogenic Therapy in a Rat Model Radiology, October 1, 2005; 237(1): 151 - 158. [Abstract] [Full Text] [PDF]

				A Nakashige, J Horiguchi, A Tamura, T Asahara, F Shimamoto, and K Ito Quantitative measurement of hepatic portal perfusion by multidetector row CT with compensation for respiratory misregistration Br. J. Radiol., September 1, 2004; 77(921): 728 - 734. [Abstract] [Full Text] [PDF]

				J. B. Kruskal, P. Thomas, R. A. Kane, and S. N. Goldberg Hepatic Perfusion Changes in Mice Livers with Developing Colorectal Cancer Metastases Radiology, May 1, 2004; 231(2): 482 - 490. [Abstract] [Full Text] [PDF]

				L. Braga, R. C. Semelka, R. Pietrobon, D. Martin, N. de Barros, and U. Guller Does Hypervascularity of Liver Metastases as Detected on MRI Predict Disease Progression in Breast Cancer Patients? Am. J. Roentgenol., May 1, 2004; 182(5): 1207 - 1213. [Abstract] [Full Text] [PDF]

				K A Miles Perfusion CT for the assessment of tumour vascularity: which protocol? Br. J. Radiol., December 1, 2003; 76(suppl_1): S36 - S42. [Abstract] [Full Text] [PDF]

				K A Miles and M R Griffiths Perfusion CT: a worthwhile enhancement? Br. J. Radiol., April 1, 2003; 76(904): 220 - 231. [Full Text] [PDF]

				M A Fuentes, C J Keith, M Griffiths, G Durbridge, and K A Miles Hepatic haemodynamics: interrelationships between contrast enhancement and perfusion on CT and Doppler perfusion indices Br. J. Radiol., January 1, 2002; 75(889): 17 - 23. [Abstract] [Full Text] [PDF]

				K. A. Miles, M. R. Griffiths, and M. A. Fuentes Standardized Perfusion Value: Universal CT Contrast Enhancement Scale that Correlates with FDG PET in Lung Nodules Radiology, August 1, 2001; 220(2): 548 - 553. [Abstract] [Full Text] [PDF]

				C. A. Cuenod, I. Leconte, N. Siauve, A. Resten, C. Dromain, B. Poulet, F. Frouin, O. Clément, and G. Frija Early Changes in Liver Perfusion Caused by Occult Metastases in Rats: Detection with Quantitative CT Radiology, February 1, 2001; 218(2): 556 - 561. [Abstract] [Full Text]

				R. G. Sheiman, K. Reynolds, and V. Raptopoulos Alterations in Hepatic Perfusion Resulting from Splanchnic Venous Luminal Compromise Caused by Pancreatic Carcinoma Am. J. Roentgenol., July 1, 2000; 175(1): 105 - 108. [Abstract] [Full Text] [PDF]

				D. H. Sheafor, J. S. Killius, E. K. Paulson, D. M. DeLong, A. M. Foti, and R. C. Nelson Hepatic Parenchymal Enhancement during Triple-Phase Helical CT: Can It Be Used to Predict Which Patients with Breast Cancer Will Develop Hepatic Metastases? Radiology, March 1, 2000; 214(3): 875 - 880. [Abstract] [Full Text]

				E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, J. E. Connolly, E. M. Marom, P. C. Goodman, R. A. Leder, M. T. Keogan, and J. E. Herndon Lung Cancer Staging and Management: Comparison of Contrast-enhanced and Nonenhanced Helical CT of the Thorax Radiology, July 1, 1999; 212(1): 56 - 60. [Abstract] [Full Text]